메뉴 건너뛰기
Hepatology
Volumn 31, Issue 5, 2000, Pages 1201-1202
Urotensin II: Better than somatostatin for portal hypertension? Comments
Author keywords

[No Author keywords available]
Indexed keywords

SOMATOSTATIN; UROTENSIN II;
EID: 0034055378     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510310524     Document Type: Note
Times cited : (9)
References (9)
  • 1
    • 0000929032 scopus 로고
    • Circulatory changes in chronic liver disease
    • Murray JF, Dawson AM, Sherlock S. Circulatory changes in chronic liver disease. Am J Med 1958;32:358-367.
    • (1958) Am J Med , vol.32 , pp. 358-367
    • Murray, J.F.1    Dawson, A.M.2    Sherlock, S.3
  • 2
    • 0001043112 scopus 로고
    • General and regional circulatory alterations in cirrhosis of the liver
    • Kontos HA, Shapiro W, Mauck HP, Patterson JL. General and regional circulatory alterations in cirrhosis of the liver. Am J Med 1964;37:526-535.
    • (1964) Am J Med , vol.37 , pp. 526-535
    • Kontos, H.A.1    Shapiro, W.2    Mauck, H.P.3    Patterson, J.L.4
  • 3
    • 0000601905 scopus 로고
    • The cardiac output at rest in Laennec's cirrhosis
    • Kowalski HJ, Abelmann WH. The cardiac output at rest in Laennec's cirrhosis.] Clin Invest 1953;32:1025-1033.
    • (1953) Clin Invest , vol.32 , pp. 1025-1033
    • Kowalski, H.J.1    Abelmann, W.H.2
  • 4
    • 0025271177 scopus 로고
    • Effect of oral propranolol on circulating catecholamines in cirrhosis: Relationship to severity of liver disease and splanchnic hemodynamics
    • Bendtsen F, Henriksen JH, Sorensen TIA, Christensen NJ. Effect of oral propranolol on circulating catecholamines in cirrhosis: relationship to severity of liver disease and splanchnic hemodynamics. J Hepatol 1990;10:198-204.
    • (1990) J Hepatol , vol.10 , pp. 198-204
    • Bendtsen, F.1    Henriksen, J.H.2    Sorensen, T.I.A.3    Christensen, N.J.4
  • 5
    • 0028961435 scopus 로고
    • Systemic hemodynamic, forearm vascular, renal, and humoral responses to sustained cardiopulmonary baroreceptor deactivation in well-compensated cirrhosis
    • Wong F, Logan A, Blendis L. Systemic hemodynamic, forearm vascular, renal, and humoral responses to sustained cardiopulmonary baroreceptor deactivation in well-compensated cirrhosis. HEPATOLOGY 1995;21:717-724.
    • (1995) Hepatology , vol.21 , pp. 717-724
    • Wong, F.1    Logan, A.2    Blendis, L.3
  • 6
    • 0029740238 scopus 로고    scopus 로고
    • Short- And long-term hemodynamic response to octreotide in portal hypertensive patients: A double-blind, controlled study
    • Zironi G, Rossi C, Siringo S, Galaverni C, Gaiani S, Piscaglia F, Bolondi L. Short- and long-term hemodynamic response to octreotide in portal hypertensive patients: a double-blind, controlled study. Liver 1996;16:225-234.
    • (1996) Liver , vol.16 , pp. 225-234
    • Zironi, G.1    Rossi, C.2    Siringo, S.3    Galaverni, C.4    Gaiani, S.5    Piscaglia, F.6    Bolondi, L.7
  • 7
    • 0031943329 scopus 로고    scopus 로고
    • Hemodynamic effects of the somatostatin analog lanreotide in humans: Placebo-controlled, cross-over dose-ranging Echo-Doppler study
    • Mottet C, Sieber CC, Nauer A, Drewe J, Fried R, Larsen F, Beglinger C. Hemodynamic effects of the somatostatin analog lanreotide in humans: placebo-controlled, cross-over dose-ranging Echo-Doppler study. HEPATOLOGY 1998;27:920-925.
    • (1998) Hepatology , vol.27 , pp. 920-925
    • Mottet, C.1    Sieber, C.C.2    Nauer, A.3    Drewe, J.4    Fried, R.5    Larsen, F.6    Beglinger, C.7
  • 9
    • 0033403318 scopus 로고    scopus 로고
    • Pharmacological treatment of portal hypertension: An evidence-based approach
    • D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 1999;19:475-505.
    • (1999) Semin Liver Dis , vol.19 , pp. 475-505
    • D'Amico, G.1    Pagliaro, L.2    Bosch, J.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.